Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

微創醫療科學有限公司*

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 00853)

CONVERSION OF CONVERTIBLE BONDS

Reference is made to the announcements of MicroPort Scientific Corporation (the "Company") dated 27 April 2014, 2 May 2014, 12 May 2014, 10 May 2019 and 9 December 2019 (together, the "Announcements") in relation to, among other things, the issue of the US$100,000,000 convertible bonds (the "Bonds") due 2019 (as extended to 2020 by resolutions of the Shareholders on 13 June 2019). Unless the context otherwise defined, capitalized terms used in this announcement shall have the same meanings as those defined in the Announcements.

The Company recently received a conversion notice from a bondholder in relation to the exercise of the conversion right attaching to the Bonds to convert Bonds in the aggregate outstanding amount of US$ 84,410,468, representing all of the outstanding amount under the Bonds, into shares of the Company (the "Conversion") at the Conversion Price of HK$6.84 per Share. Accordingly, 95,949,033 New Shares, representing approximately 5.89% of the issued share capital of the Company immediately before the Conversion and approximately 5.56% of the issued share capital of the Company as enlarged by the issue of the New Shares, have been allotted to the bondholder in accordance with the terms and conditions of the Bonds. Upon completion of the Conversion, the Bonds will be fully converted and no longer outstanding.

The New Shares will rank pari passu with all existing shares of the Company as at the date of the allotment and among themselves in all respects.

1

The shareholding structure of the Company immediately before and after the Conversion and the issue of the New Shares is set out below:

Immediately before the

Immediately after the

Conversion and the issue of

Conversion and the issue of

the New Shares

the New Shares

% of issued

% of issued

share capital

share capital

Number of

of the

Number of

of the

Shareholder

Shares

Company

Shares

Company

Otsuka Medical Devices Co., Ltd.

382,994,120

23.50

382,994,120

22.20

We'Tron Capital Limited

234,384,296

14.38

234,384,296

13.58

Shanghai Zhangjiang (Group) Co., Ltd. and

its associates

221,748,050

13.61

221,748,050

12.85

Erudite Holdings Limited and its associates

108,238,011

6.64

108,238,011

6.27

Bondholder who exercised its conversion

right under the Bonds

-

-

95,949,033

5.56

Other public Shareholders

682,096,930

41.86

682,096,930

39.53

Total

1,629,461,407

100.00

1,725,410,440

100.00

By order of the Board

MicroPort Scientific Corporation

Dr. Zhaohua Chang

Chairman

Shanghai, the PRC, 24 February 2020

As at the date of this announcement, the executive Director is Dr. Zhaohua Chang; the non-executive Directors are Mr. Norihiro Ashida, Mr. Hiroshi Shirafuji and Mr. Hongliang Yu; and the independent non-executive Directors are Mr. Jonathan H. Chou, Dr. Guoen Liu and Mr. Chunyang Shao.

*  For identification purpose only

2

Attachments

  • Original document
  • Permalink

Disclaimer

MicroPort Scientific Corporation published this content on 24 February 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 February 2020 14:52:02 UTC